Nuwellis, Inc. (NUWE)
0.3221
-0.17
(-33.97%)
USD |
NASDAQ |
Oct 23, 16:00
0.3402
+0.02
(+5.62%)
After-Hours: 20:00
Nuwellis EPS Diluted (Quarterly) : -26.63 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.63 |
| March 31, 2026 | -76.56 |
| December 31, 2025 | -52.49 |
| September 30, 2025 | 19.63 |
| June 30, 2025 | -2134.34 |
| March 31, 2025 | -0.6888 |
| December 31, 2024 | -640.77 |
| September 30, 2024 | 1.744 |
| June 30, 2024 | -18.86 |
| March 31, 2024 | -21.10 |
| December 31, 2023 | -78.39 |
| September 30, 2023 | -63.28 |
| June 30, 2023 | -127.69 |
| March 31, 2023 | -201.58 |
| December 31, 2022 | -175.09 |
| September 30, 2022 | -1285.34 |
| June 30, 2022 | -1423.52 |
| March 31, 2022 | -1485.61 |
| December 31, 2021 | -1446.10 |
| September 30, 2021 | -2599.59 |
| June 30, 2021 | -2534.98 |
| March 31, 2021 | -4365.86 |
| December 31, 2020 | -3947.72 |
| September 30, 2020 | -7565.25 |
| June 30, 2020 | -10859.10 |
| Date | Value |
|---|---|
| March 31, 2020 | -39320.40 |
| December 31, 2019 | -117111.8 |
| September 30, 2019 | -178928.4 |
| June 30, 2019 | -202679.4 |
| March 31, 2019 | -1.205M |
| December 31, 2018 | -877957.5 |
| September 30, 2018 | -892260.6 |
| June 30, 2018 | -1.368M |
| March 31, 2018 | -1.588M |
| December 31, 2017 | -6.611M |
| September 30, 2017 | -6.686M |
| June 30, 2017 | -9.726M |
| March 31, 2017 | -17.50M |
| December 31, 2016 | -117.46M |
| September 30, 2016 | -172.96M |
| June 30, 2016 | -202.86M |
| March 31, 2016 | -229.32M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -317.52M |
| June 30, 2015 | -308.70M |
| March 31, 2015 | -352.80M |
| December 31, 2014 | -352.80M |
| September 30, 2014 | -317.52M |
| June 30, 2014 | -335.16M |
| March 31, 2014 | -335.16M |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GlucoTrack, Inc. | -11.42 |
| Abbott Laboratories | 0.5293 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.828M |
| Revenue (Quarterly) | 1.969M |
| Total Expenses (Quarterly) | 6.797M |
| Enterprise Value | -3.527M |
| Gross Profit Margin (Quarterly) | 76.08% |
| Profit Margin (Quarterly) | -245.2% |
| Earnings Yield | -42.24K% |
| Normalized Earnings Yield | -76524.84 |